#stance=stance1
#originalStanceText=Yes
#originalTopic=Debate:_Single-payer_universal_health_care
 Profit interests corrupt investments in medical innovation Drug and medical companies are driven, in large part, by the bottom-line of profits. Their investments in new drugs and medical innovations are driven by these interests. But, what is likely to make the most money is often at odds with public and patient interests. 
